等待开盘 03-27 09:30:00 美东时间
0.000
NaN.00%
Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has commenced a best-efforts
03-24 05:35
The Q1 earnings report for Outlook Therapeutics (NASDAQ:OTLK) was released on T...
02-17 21:12
Outlook Therapeutics' stock fell to a new low due to FDA rejection of its Lytenava filing for wet AMD. Efficacy evidence remains key issue.
01-02 21:18
Shares of Baidu Inc (NASDAQ:BIDU) rose sharply in pre-market trading after the ...
01-02 17:30
U.S. stock futures up, Apple reduces Vision Pro production, TSMC gets U.S. export license, VS Media announces share combination.
01-02 15:19